Irland - Englisch - HPRA (Health Products Regulatory Authority)

imbat limited - budesonide; formoterol fumatrate dihydrate - powder for inhalation - 400mcg/12mcg mcg/dose - adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics; formoterol and budesonide

Irland - Englisch - HPRA (Health Products Regulatory Authority)

pco manufacturing ltd. - formoterol fumatrate dihydrate; budesonide - inhalation powder - 400/12 microgram(s)/dose - adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics; formoterol and budesonide

Irland - Englisch - HPRA (Health Products Regulatory Authority)

imed healthcare ltd. - formoterol fumatrate dihydrate; budesonide - inhalation powder - 200 µg/6 µg/inhalation - adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics; formoterol and budesonide

Irland - Englisch - HPRA (Health Products Regulatory Authority)

imbat limited - formoterol fumatrate dihydrate; budesonide - inhalation powder - 200 µg/6 microgram(s) - adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics; formoterol and budesonide

Australien - Englisch - Department of Health (Therapeutic Goods Administration)

astrazeneca pty ltd - budesonide, quantity: 80 microgram; formoterol fumarate dihydrate, quantity: 4.5 microgram - inhalation, pressurised - excipient ingredients: povidone; macrogol 1000; apaflurane - asthma symbicort rapihaler is indicated in adults and adolescents (12 years and older), for the treatment of asthma to achieve overall asthma control, including the relief of symptoms and the reduction of the risk of exacerbations (see section 4.2 dose and method of administration). chronic obstructive pulmonary disease (copd) symbicort 200/6 is indicated for the symptomatic treatment of moderate to severe copd (fev1 < or = 50% predicted normal) in adults with frequent symptoms despite long-acting bronchodilator use, and/or a history of recurrent exacerbations. symbicort is not indicated for the initiation of bronchodilator therapy in copd.

Australien - Englisch - Department of Health (Therapeutic Goods Administration)

astrazeneca pty ltd - budesonide, quantity: 80 microgram; formoterol fumarate dihydrate, quantity: 2.25 microgram - inhalation, pressurised - excipient ingredients: apaflurane; macrogol 1000; povidone - asthma rilast rapihaler is indicated in adults and adolescents (12 years and older), for the treatment of asthma to achieve overall asthma control, including the relief of symptoms and the reduction of the risk of exacerbations (see section 4.2 dose and method of administration). chronic obstructive pulmonary disease (copd) rilast rapihaler 200/6 is indicated for the symptomatic treatment of moderate to severe copd (fev1 < or = 50% predicted normal) in adults with frequent symptoms despite long-acting bronchodilator use, and/or a history of recurrent exacerbations. is not indicated for the initiation of bronchodilator therapy in copd.

Australien - Englisch - Department of Health (Therapeutic Goods Administration)

astrazeneca pty ltd - budesonide, quantity: 160 microgram; formoterol fumarate dihydrate, quantity: 4.5 microgram - inhalation, pressurised - excipient ingredients: povidone; macrogol 1000; apaflurane - asthma indicated in adults and adolescents (12 years and older), for the treatment of asthma to achieve overall asthma control, including the relief of symptoms and the reduction of the risk of exacerbations (see section 4.2 dose and method of administration). chronic obstructive pulmonary disease (copd) indicated for the symptomatic treatment of moderate to severe copd (fev1 < or = 50% predicted normal) in adults with frequent symptoms despite long-acting bronchodilator use, and/or a history of recurrent exacerbations. not indicated for the initiation of bronchodilator therapy in copd.

Irland - Englisch - HPRA (Health Products Regulatory Authority)

astrazeneca uk limited - budesonide; formoterol fumatrate dihydrate - powder for inhalation - 200/6 microgram(s) - adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics

Irland - Englisch - HPRA (Health Products Regulatory Authority)

astrazeneca ab - budesonide; formoterol fumatrate dihydrate - inhalation powder - 200 mcg/6 microgram(s) - adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics

Irland - Englisch - HPRA (Health Products Regulatory Authority)

astrazeneca uk limited - budesonide; formoterol fumatrate dihydrate - powder for inhalation - 400/12 microgram(s) - o3ak07